Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Multiple Myeloma: Diagnosis and Treatment | AAFP
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
Monoclonals - an overview | ScienceDirect Topics
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Monoclonal Gammopathy–Associated Peripheral Neuropathy: Diagnosis and Management - Mayo Clinic Proceedings
MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease | SpringerLink
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal Gammopathy of Undetermined Significance (MGUS)
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study - Clinical Lymphoma, Myeloma and Leukemia
